Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Investors question green tint of Teva's $5bn sustainability bond | Financial Times
Michael (Mickey) Ben Moshe - VP Finance, Corporate Treasury @ Teva Pharmaceuticals - Teva Pharmaceuticals | LinkedIn
Teva responds to Mylan backlash with planned launch of generic EpiPen | Healthcare Finance News
Teva Pharmaceutical S&P rating outlook changed to stable | Seeking Alpha
Teva Reports Third Quarter 2021 Financial Results | Business Wire
Teva Reports First Quarter 2023 Financial Results and Reaffirms 2023 Non-GAAP Outlook
Teva Seeks New CFO as It Faces High Debt Levels, Opioid Litigation - WSJ
Teva Beats Analysts on Second Quarter Operating Income, Revenues | Ctech
Teva Reports Third Quarter 2020 Financial Results | Business Wire
Teva (TEVA) Beats on Q3 Earnings, Lags Sales, Shares Up
Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley Fool
Here's Why Teva Pharmaceutical Industries (NYSE:TEVA) Is Weighed Down By Its Debt Load - Simply Wall St News
Teva Pharmaceuticals on Twitter: "Teva Global Operations NA and Complex Manufacturing Finance Leader Mayra Avila shares how she confronted a challenge head-on to find her voice. Read her story and learn more
Amit Hazan - Head of Corporate Finance & Banking Relations - Teva Pharmaceuticals | LinkedIn
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
Teva Pharmaceuticals to Cut 25% of Jobs in Huge Reshaping - The New York Times
Teva reaches opioid settlement, Credit Suisse names new CEO, Twitter to hold shareholder vote - YouTube
Teva Pharmaceuticals Industries Ltd. to buy Rimsa for $2.3 billion - Pittsburgh Business Times
Jose Lassalle - Finance Manager - Teva Pharmaceuticals | LinkedIn